Early transcutaneous electrical nerve stimulation reduces hyperalgesia and decreases activation of spinal glial cells in mice with neuropathic pain

Pain

Volumn 155, Issue 9, 2014, Pages 1888-1901

  Matsuo, Hideaki ^a   Uchida, Kenzo ^b   Nakajima, Hideaki ^b   Guerrero, Alexander Rodriguez ^b   Watanabe, Shuji ^b   Takeura, Naoto ^b   Sugita, Daisuke ^b   Shimada, Seiichiro ^a   Nakatsuka, Terumasa ^c   Baba, Hisatoshi ^b  

^a UNIVERSITY OF FUKUI HOSPITAL   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c KANSAI UNIVERSITY OF HEALTH SCIENCES   (Japan)

Author keywords

Microglia; Neuropathic pain; Opioid receptor; P38 MAPK; Spinal cord; Transcutaneous electrical nerve stimulation (TENS)

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; OPIATE RECEPTOR; PROTEIN KINASE C; NALOXONE; NARCOTIC ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; GLIA CELL; HYPERALGESIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; MICROGLIA; MOUSE; NERVE CELL; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; SPINAL CORD DORSAL HORN; SPINAL GLIAL CELL; TRANSCUTANEOUS NERVE STIMULATION; ANIMAL; DRUG EFFECTS; GLIA; METABOLISM; NEURALGIA; SPINAL CORD; STIMULATION;

ANIMALS; CYTOKINES; HYPERALGESIA; MICE; NALOXONE; NARCOTIC ANTAGONISTS; NEURALGIA; NEUROGLIA; NEURONS; PHYSICAL STIMULATION; RECEPTORS, OPIOID; SPINAL CORD; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 84926420823     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2014.06.022     Document Type: Article

References (74)

1. Back SK, Lee J, Hong SK, Na HS. Loss of spinal mu-opioid receptor is associated with mechanical allodynia in a rat model of peripheral neuropathy. PAIN 2006;123:117-26.
2. Baron R. Mechanisms of disease: neuropathic pain-a clinical perspective. Nat Clin Pract Neurol 2006;2:95-106.
3. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994;79:59-68.
4. Calvo M, Dawes JM, Bennett DL. The role of the immune system in the generation of neuropathic pain. Lancet Neurol 2012;11:629-42.
5. Chabal C. Transcutaneous electrical nerve stimulation. In: Loeser JD, editor. Bonica's management of pain. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 1842-7.
6. Cheing GL, Luk ML. Transcutaneous electrical nerve stimulation for neuropathic pain. J Hand Surg Br 2005;30:50-5.
7. Ciruela A, Dixon AK, Bramwell S, Gonzalez MI, Pinnock RD, Lee K. Identification of MEK1 as a novel target for the treatment of neuropathic pain. Br J Pharmacol 2003;138:751-6.
8. Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. PAIN 2000;87:149-58.
9. DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmune activation in persistent pain. PAIN 2001;90:1-6.
10. DeSantana JM, Walsh DM, Vance C, Rakel BA, Sluka KA. Effectiveness of transcutaneous electrical nerve stimulation for treatment of hyperalgesia and pain. Curr Rheumatol Rep 2008;10:492-9.
11. Echeverry S, Shi XQ, Zhang J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. PAIN 2008;135:37-47.
12. Gim GT, Lee JH, Park E, Sung YH, Kim CJ, Hwang WW, Chu JP, Min BI. Electroacupuncture attenuates mechanical and warm allodynia through suppression of spinal glial activation in a rat model of neuropathic pain. Brain Res Bull 2011;86:403-11.
13. Guerrero AR, Uchida K, Nakajima H, Watanabe S, Nakamura M, Johnson WE, Baba H. Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation 2012;9:40.
14. Han JS, Chen XH, Sun SL, Xu XJ, Yuan Y, Yan SC, Hao JX, Terenius L. Effect of low-and high-frequency TENS on Met-enkephalin-Arg-Phe and dynorphin A immunoreactivity in human lumbar CSF. PAIN 1991;47:295-8.
15. Hanai F. Effect of electrical stimulation of peripheral nerves on neuropathic pain. Spine (Phila Pa 1976) 2000;25:1886-92.
16. Hansson P, Lundeberg T. Transcutaneous electrical nerve stimulation, vibration and acupuncture as pain-relieving measures. In: Melzack R, Wall PD, editors. Textbook of pain. London: Churchill Livingstone; 1999. p. 1341-51.
17. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. PAIN 1988;32:77-88.
18. Hassenbusch SJ, Stanton-Hicks M, Schoppa D, Walsh JG, Covington EC. Longterm results of peripheral nerve stimulation for reflex sympathetic dystrophy. J Neurosurg 1996;84:415-23.
19. Hughes Jr GS, Lichstein PR, Whitlock D, Harker C. Response of plasma betaendorphins to transcutaneous electrical nerve stimulation in healthy subjects. Phys Ther 1984;64:1062-6.
20. Inoue K, Tsuda M. Microglia and neuropathic pain. Glia 2009;57:1469-79.
21. Inoue T, Takenoshita M, Shibata M, Nishimura M, Sakaue G, Shibata SC, Mashimo T. Long-lasting effect of transcutaneous electrical nerve stimulation on the thermal hyperalgesia in the rat model of peripheral neuropathy. J Neurol Sci 2003;211:43-7.
22. Ji RR, Gereau 4th RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009;60:135-48.
23. Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 2003;26:696-705.
24. Ji RR, Suter MR. P38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007;3:33.
25. Jin SX, Zhuang ZY, Woolf CJ, Ji RR. P38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 2003;23:4017-22.
26. Johansson F, Almay BG, Von Knorring L, Terenius L. Predictors for the outcome of treatment with high frequency transcutaneous electrical nerve stimulation in patients with chronic pain. PAIN 1980;9:55-61.
27. Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, Leinwand L, Maier SF, Watkins LR. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 2004;24:7353-65.
28. Katano T, Nakazawa T, Nakatsuka T, Watanabe M, Yamamoto T, Ito S. Involvement of spinal phosphorylation cascade of Tyr1472-NR2B, Thr286-CaMKII, and Ser831-GluR1 in neuropathic pain. Neuropharmacology 2011;60:609-16.
29. Kawasaki Y, Kohno T, Ji RR. Different effects of opioid and cannabinoid receptor agonists on C-fiber-induced extracellular signal-regulated kinase activation in dorsal horn neurons in normal and spinal nerve-ligated rats. J Pharmacol Exp Ther 2006;316:601-7.
30. Kohno T, Ji RR, Ito N, Allchorne AJ, Befort K, Karchewski LA, Woolf CJ. Peripheral axonal injury results in reduced mu opioid receptor pre-and post-synaptic action in the spinal cord. PAIN 2005;117:77-87.
31. Kumar S, Boehm J, Lee JC. P38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2003;2:717-26.
32. Lee MJ, Shin TJ, Lee JE, Choo H, Koh HY, Chung HJ, Pae AN, Lee SC, Kim HJ. KST5468, a new T-type calcium channel antagonist, has an antinociceptive effect on inflammatory and neuropathic pain models. Pharmacol Biochem Behav 2010;97:198-204.
33. Leem JW, Park ES, Paik KS. Electrophysiological evidence for the antinociceptive effect of transcutaneous electrical stimulation on mechanically evoked responsiveness of dorsal horn neurons in neuropathic rats. Neurosci Lett 1995;192:197-200.
34. Ma W, Quirion R. Increased phosphorylation of cyclic AMP response elementbinding protein (CREB) in the superficial dorsal horn neurons following partial sciatic nerve ligation. PAIN 2001;93:295-301.
35. Ma W, Quirion R. Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun Nterminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus. PAIN 2002;99:175-84.
36. Maeda Y, Lisi TL, Vance CG, Sluka KA. Release of GABA and activation of GABAA in the spinal cord mediates the effects of TENS in rats. Brain Res 2007;1136:43-50.
37. Malmberg AB, Chen C, Tonegawa S, Basbaum AI. Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma. Science 1997;278:279-83.
38. Mao J, Price DD, Phillips LL, Lu J, Mayer DJ. Increases in protein kinase C gamma immunoreactivity in the spinal cord dorsal horn of rats with painful mononeuropathy. Neurosci Lett 1995;198:75-8.
39. Marchand F, Perretti M, McMahon SB. Role of the immune system in chronic pain. Nat Rev Neurosci 2005;6:521-32.
40. Martins DF, Mazzardo-Martins L, Gadotti VM, Nascimento FP, Lima DA, Speckhann B, Favretto GA, Bobinski F, Cargnin-Ferreira E, Bressan E, Dutra RC, Calixto JB, Santos AR. Ankle joint mobilization reduces axonotmesis-induced neuropathic pain and glial activation in the spinal cord and enhances nerve regeneration in rats. PAIN 2011;152:2653-61.
41. Mika J, Zychowska M, Popiolek-Barczyk K, Rojewska E, Przewlocka B. Importance of glial activation in neuropathic pain. Eur J Pharmacol 2013;716:106-19.
42. Miletic V, Bowen KK, Miletic G. Loose ligation of the rat sciatic nerve is accompanied by changes in the subcellular content of protein kinase C beta II and gamma in the spinal dorsal horn. Neurosci Lett 2000;288:199-202.
43. Nakajima H, Uchida K, Guerrero AR, Watanabe S, Sugita D, Takeura N, Yoshida A, Long G, Wright KT, Johnson WE, Baba H. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma 2012;29: 1614-25.
44. Nam TS, Choi Y, Yeon DS, Leem JW, Paik KS. Differential antinociceptive effect of transcutaneous electrical stimulation on pain behavior sensitive or insensitive to phentolamine in neuropathic rats. Neurosci Lett 2001;301:17-20.
45. Obata K, Yamanaka H, Kobayashi K, Dai Y, Mizushima T, Katsura H, Fukuoka T, Tokunaga A, Noguchi K. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci 2004;24:10211-22.
46. Porreca F, Tang QB, Bian D, Riedl M, Elde R, Lai J. Spinal opioid mu receptor expression in lumbar spinal cord of rats following nerve injury. Brain Res 1998;795:197-203.
47. Radhakrishnan R, King EW, Dickman JK, Herold CA, Johnston NF, Spurgin ML, Sluka KA. Spinal 5-HT2 and 5-HT3 receptors mediate low, but not high, frequency TENS-induced antihyperalgesia in rats. PAIN 2003;105:205-13.
48. Radhakrishnan R, Sluka KA. Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats. Neuropharmacology 2003;45:1111-9.
49. Saiwai H, Ohkawa Y, Yamada H, Kumamaru H, Harada A, Okano H, Yokomizo T, Iwamoto Y, Okada S. The LTB4-BLT1 axis mediates neutrophil infiltration and secondary injury in experimental spinal cord injury. Am J Pathol 2010;176:2352-66.
50. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007;10:1361-8.
51. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 1991;88:7438-42.
52. Shibata K, Sugawara T, Fujishita K, Shinozaki Y, Matsukawa T, Suzuki T, Koizumi S. The astrocyte-targeted therapy by Bushi for the neuropathic pain in mice. PLoS ONE 2011;6:e23510.
53. Sluka KA, Deacon M, Stibal A, Strissel S, Terpstra A. Spinal blockade of opioid receptors prevents the analgesia produced by TENS in arthritic rats. J Pharmacol Exp Ther 1999;289:840-6.
54. Sluka KA, Vance CG, Lisi TL. High-frequency, but not low-frequency, transcutaneous electrical nerve stimulation reduces aspartate and glutamate release in the spinal cord dorsal horn. J Neurochem 2005;95:1794-801.
55. Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain 2003;4:109-21.
56. Somers DL, Clemente FR. High-frequency transcutaneous electrical nerve stimulation alters thermal but not mechanical allodynia following chronic constriction injury of the rat sciatic nerve. Arch Phys Med Rehabil 1998;79:1370-6.
57. Somers DL, Clemente FR. The relationship between dorsal horn neurotransmitter content and allodynia in neuropathic rats treated with high-frequency transcutaneous electric nerve stimulation. Arch Phys Med Rehabil 2003;84:1575-83.
58. Somers DL, Clemente FR. Transcutaneous electrical nerve stimulation for the management of neuropathic pain: the effects of frequency and electrode position on prevention of allodynia in a rat model of complex regional pain syndrome type II. Phys Ther 2006;86:698-709.
59. Somers DL, Clemente FR. Contralateral high or a combination of high-and lowfrequency transcutaneous electrical nerve stimulation reduces mechanical allodynia and alters dorsal horn neurotransmitter content in neuropathic rats. J Pain 2009;10:221-9.
60. Stirling DP, Yong VW. Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J Neurosci Res 2008;86:1944-58.
61. Suter MR, Wen YR, Decosterd I, Ji RR. Do glial cells control pain? Neuron Glia Biol 2007;3:255-68.
62. Svensson CI, Brodin E. Spinal astrocytes in pain processing: non-neuronal cells as therapeutic targets. Mol Interv 2010;10:25-38.
63. Tan Y, Uchida K, Nakajima H, Guerrero AR, Watanabe S, Hirai T, Takeura N, Liu SY, Johnson WE, Baba H. Blockade of interleukin 6 signaling improves the survival rate of transplanted bone marrow stromal cells and increases locomotor function in mice with spinal cord injury. J Neuropathol Exp Neurol 2013;72:980-93.
64. Treede RD, Jensen TS, Campbell JN, Cruccu G, Dostrovsky JO, Griffin JW, Hansson P, Hughes R, Nurmikko T, Serra J. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-5.
65. Truin M, van Kleef M, Linderoth B, Smits H, Janssen SP, Joosten EA. Increased efficacy of early spinal cord stimulation in an animal model of neuropathic pain. Eur J Pain 2011;15:111-7.
66. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in ''small'' glia. Trends Neurosci 2005;28:101-7.
67. Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004;45:89-95.
68. Watkins LR, Maier SF. Glia: a novel drug discovery target for clinical pain. Nat Rev Drug Discov 2003;2:973-85.
69. Watkins LR, Milligan ED, Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci 2001;24:450-5.
70. Woolf CJ, Mitchell D, Barrett GD. Antinociceptive effect of peripheral segmental electrical stimulation in the rat. PAIN 1980;8:237-52.
71. Zhang X, Bao L, Shi TJ, Ju G, Elde R, Hokfelt T. Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 1998;82:223-40.
72. Zhuang ZY, Gerner P, Woolf CJ, Ji RR. ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. PAIN 2005;114:149-59.
73. Zhuang ZY, Wen YR, Zhang DR, Borsello T, Bonny C, Strichartz GR, Decosterd I, Ji RR. A peptide c-Jun N-terminal kinase (JNK) inhibitor blocks mechanical allodynia after spinal nerve ligation: respective roles of JNK activation in primary sensory neurons and spinal astrocytes for neuropathic pain development and maintenance. J Neurosci 2006;26:3551-60.
74. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. PAIN 1983;16:109-10.